Variability in total serum IgE over 1 year in severe asthmatics

BACKGROUND: Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgE(tot)) in asthmatics remains poorly documented. METHODS: In this prospective study, sIgE(tot) levels wer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Allergy Asthma Clin Immunol
Main Authors: Louis, Renaud, Pilette, Charles, Michel, Olivier, Michils, Alain, Brusselle, Guy, Poskin, Antoine, Van Schoor, Jan, Denhaerynck, Kris, Vancayzeele, Stefaan, Abraham, Ivo, Gurdain, Sandra
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441212/
https://ncbi.nlm.nih.gov/pubmed/30976287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-019-0331-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki